Kamala Harris lost 2024 US election, 10 large-cap stocks performed poorly: Moderna, Honda, Akamai, ADS, AstraZeneca, ...

I t’s not just officially cold and flu season, it’s RSV season. RSV, which stands for respiratory syncytial virus, is a highly contagious illness that affects people of all ag ...

Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...

Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations.

Investing.com - Moderna (NASDAQ:MRNA) has reported a shallower-than-anticipated loss in the third quarter and announced changes at its leadership team, as the drugmaker looks to address issues ...

COVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as myocarditis and ...

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably ... A rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported ...

Almost as soon as the COVID-19 pandemic started, the ruling class campaigned vigorously against any measures that, while fighting against the virus, might interfere with their ability to ...

A Covid vaccine compensation scheme could be set up after thousands claimed they have been left disabled as a result of the AstraZeneca jab, The Telegraph has learnt. The Health Secretary is ...

Or sign-in if you have an account. An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung cancer. BNT116 is a striking example ...

Before joining BeiGene, Yin spent 15 years with AstraZeneca, having served in various posts at the British drugmaker, including as head of its oncology business in China. Yin has been detained by ...

WILMETTE, Ill., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biotechnology company focused on developing innovative treatments for patients with ...